Literature DB >> 26660451

Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function.

Andreas Daiber1, Fabio Di Lisa2, Matthias Oelze1, Swenja Kröller-Schön1, Sebastian Steven1,3, Eberhard Schulz1, Thomas Münzel1.   

Abstract

Cardiovascular diseases are associated with and/or caused by oxidative stress. This concept has been proven by using the approach of genetic deletion of reactive species producing (pro-oxidant) enzymes as well as by the overexpression of reactive species detoxifying (antioxidant) enzymes leading to a marked reduction of reactive oxygen and nitrogen species (RONS) and in parallel to an amelioration of the severity of diseases. Likewise, the development and progression of cardiovascular diseases is aggravated by overexpression of RONS producing enzymes as well as deletion of antioxidant RONS detoxifying enzymes. Thus, the consequences of the interaction (redox crosstalk) of superoxide/hydrogen peroxide produced by mitochondria with other ROS producing enzymes such as NADPH oxidases (Nox) are of outstanding importance and will be discussed including the consequences for endothelial nitric oxide synthase (eNOS) uncoupling as well as the redox regulation of the vascular function/tone in general (soluble guanylyl cyclase, endothelin-1, prostanoid synthesis). Pathways and potential mechanisms leading to this crosstalk will be analysed in detail and highlighted by selected examples from the current literature including hypoxia, angiotensin II-induced hypertension, nitrate tolerance, aging and others. The general concept of redox-based activation of RONS sources via "kindling radicals" and enzyme-specific "redox switches" will be discussed providing evidence that mitochondria represent key players and amplifiers of the burden of oxidative stress. LINKED ARTICLES: This article is part of a themed section on Redox Biology and Oxidative Stress in Health and Disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.12/issuetoc.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26660451      PMCID: PMC5446573          DOI: 10.1111/bph.13403

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  227 in total

1.  Superoxide production and expression of nox family proteins in human atherosclerosis.

Authors:  Dan Sorescu; Daiana Weiss; Bernard Lassègue; Roza E Clempus; Katalin Szöcs; George P Sorescu; Liisa Valppu; Mark T Quinn; J David Lambeth; J David Vega; W Robert Taylor; Kathy K Griendling
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

2.  Regulation by mitochondrial superoxide and NADPH oxidase of cellular formation of nitrated cyclic GMP: potential implications for ROS signalling.

Authors:  Khandaker Ahtesham Ahmed; Tomohiro Sawa; Hideshi Ihara; Shingo Kasamatsu; Jun Yoshitake; Md Mizanur Rahaman; Tatsuya Okamoto; Shigemoto Fujii; Takaaki Akaike
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

Review 3.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 4.  Oxidative stress and vascular inflammation in aging.

Authors:  Mariam El Assar; Javier Angulo; Leocadio Rodríguez-Mañas
Journal:  Free Radic Biol Med       Date:  2013-07-10       Impact factor: 7.376

5.  Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts.

Authors:  Nina Kaludercic; Andrea Carpi; Takahiro Nagayama; Vidhya Sivakumaran; Guangshuo Zhu; Edwin W Lai; Djahida Bedja; Agnese De Mario; Kevin Chen; Kathleen L Gabrielson; Merry L Lindsey; Karel Pacak; Eiki Takimoto; Jean C Shih; David A Kass; Fabio Di Lisa; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2013-05-22       Impact factor: 8.401

Review 6.  Preconditioning potentiates redox signaling and converts death signal into survival signal.

Authors:  Dipak K Das; Nilanjana Maulik
Journal:  Arch Biochem Biophys       Date:  2003-12-15       Impact factor: 4.013

7.  Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction.

Authors:  Abdulrahman K Doughan; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2007-12-20       Impact factor: 17.367

Review 8.  Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole.

Authors:  Fabio Di Lisa; Paolo Bernardi
Journal:  Cardiovasc Res       Date:  2006-02-23       Impact factor: 10.787

9.  Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism.

Authors:  George R Thomas; Jonathan M DiFabio; Tommaso Gori; John D Parker
Journal:  J Am Coll Cardiol       Date:  2007-03-12       Impact factor: 24.094

10.  Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.

Authors:  Swenja Schuhmacher; Matthias Oelze; Franziska Bollmann; Hartmut Kleinert; Christian Otto; Tjebo Heeren; Sebastian Steven; Michael Hausding; Maike Knorr; Andrea Pautz; Kurt Reifenberg; Eberhard Schulz; Tommaso Gori; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Diabetes       Date:  2011-08-15       Impact factor: 9.461

View more
  77 in total

1.  In vitro antioxidant efficacy and the therapeutic potential of Wendlandia heynei (Schult.) Santapau & Merchant against bisphenol A-induced hepatotoxicity in rats.

Authors:  Sonia Maryam; Muhammad Rashid Khan; Sayed Afzal Shah; Zartash Zahra; Muhammad Majid; Moniba Sajid; Saima Ali
Journal:  Toxicol Res (Camb)       Date:  2018-08-08       Impact factor: 3.524

2.  Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction.

Authors:  Aarron Phensy; Kathy L Lindquist; Karen A Lindquist; Dania Bairuty; Esha Gauba; Lan Guo; Jing Tian; Heng Du; Sven Kroener
Journal:  J Neurosci       Date:  2020-06-30       Impact factor: 6.167

3.  Pharmacology of oxidative stress: translational opportunities.

Authors:  Andreas Daiber; Fabio Di Lisa; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2017-06       Impact factor: 8.739

4.  Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice.

Authors:  Wenqi Gao; Wei Wang; Jing Zhang; Pengyi Deng; Jun Hu; Jian Yang; Zhifang Deng
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

Review 5.  Systems Biology Approaches to Redox Metabolism in Stress and Disease States.

Authors:  Rui-Sheng Wang; William M Oldham; Bradley A Maron; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2017-12-20       Impact factor: 8.401

Review 6.  Fibrin turnover and pleural organization: bench to bedside.

Authors:  Andrey A Komissarov; Najib Rahman; Y C Gary Lee; Galina Florova; Sreerama Shetty; Richard Idell; Mitsuo Ikebe; Kumuda Das; Torry A Tucker; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

Review 7.  Reactive species-induced microvascular dysfunction in ischemia/reperfusion.

Authors:  Hong Yu; Ted Kalogeris; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2019-03-05       Impact factor: 7.376

Review 8.  GPER modulators: Opportunity Nox on the heels of a class Akt.

Authors:  Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-08       Impact factor: 4.292

Review 9.  Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.

Authors:  Rongrong Zhang; Mengxue Xu; Yu Wang; Fei Xie; Gang Zhang; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2016-09-30       Impact factor: 5.590

Review 10.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.